Menu Search
Equities

EchoIQ Ltd

EIQ:ASX

EchoIQ Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.245
  • Today's Change0.02 / 8.89%
  • Shares traded5.73m
  • 1 Year change+44.12%
  • Beta1.6010
Data delayed at least 20 minutes, as of Nov 18 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year EchoIQ Ltd had revenues fall -58.54% from 107.33k to 44.50k, though the company grew net income from a loss of 7.86m to a smaller loss of 5.41m.
Gross margin--
Net profit margin-12,155.39%
Operating margin-16,642.88%
Return on assets-58.04%
Return on equity-76.45%
Return on investment-76.45%
More ▼

Cash flow in AUDView more

In 2024, cash reserves at EchoIQ Ltd fell by 1.16m. Cash Flow from Financing totalled 2.77m or 6,213.48% of revenues. In addition the company used 3.92m for operations while cash from investing was breakeven.
Cash flow per share-0.0097
Price/Cash flow per share--
Book value per share0.0126
Tangible book value per share0.0018
More ▼

Balance sheet in AUDView more

EchoIQ Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio1.65
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.